Ocuphire Pharma Appoints New Leadership Team to Advance APX3330 for Diabetic Retinopathy
On February 14, 2024, Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, made significant changes to its leadership team. Ash ...
On February 14, 2024, Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, made significant changes to its leadership team. Ash ...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.